Get the Stockscreener App
3.425
2.70%
-0.095
Nephros Inc stock is traded at $3.425, with a volume of 6,893.
It is down -2.70% in the last 24 hours and down -20.16% over the past month.
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
See More
Previous Close:
$3.52
Open:
$3.54
24h Volume:
6,893
Relative Volume:
0.12
Market Cap:
$37.20M
Revenue:
$19.12M
Net Income/Loss:
$776.00K
P/E Ratio:
48.51
EPS:
0.0706
Net Cash Flow:
$-348.00K
1W Performance:
+4.10%
1M Performance:
-20.16%
6M Performance:
+10.31%
1Y Performance:
-37.61%
1-Day Range:
$3.425
$3.66
1-Week Range:
$3.31
$3.70
52-Week Range:
$2.6629
$6.42
Nephros Inc Stock (NEPH) Company Profile
Name
Nephros Inc
Sector
Industry
Phone
201.343.5202
Address
380 LACKAWANNA PLACE, SOUTH ORANGE, NJ
Compare NEPH vs ISRG, BDX, RMD, ALC, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEPH
Nephros Inc
|
3.425 | 37.20M | 19.12M | 776.00K | -348.00K | 0.0706 |
ISRG
Intuitive Surgical Inc
|
426.28 | 150.60B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
192.66 | 52.48B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
241.63 | 33.98B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.72 | 32.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
36.63 | 32.14B | 29.14B | 1.07B | 1.05B | 1.1956 |
Nephros Inc Stock (NEPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-26 | Initiated | Northland Capital | Market Perform |
| Jan-26-21 | Initiated | B. Riley Securities | Buy |
Nephros Inc Stock (NEPH) Latest News
Nephros Announces Virtual 2026 Annual Meeting for November 25 with Updated Stockholder Deadlines - Kalkine Media
Nephros Stock Price Forecast. Should You Buy NEPH? - StockInvest.us
Nephros CEO to present at Maxim Group virtual conference - scanx.trade
NEPHROS INC (NASDAQ: NEPH) Director Amron Arthur H Executes 43,295 Share Transactions - kalkinemedia.com
Nephros Q2FY26 Results: Net profit rises 400% YoY to $1.2 million - scanx.trade
Nephros Q2 2026 Earnings Call: Complete Transcript - Benzinga
Nephros (NEPH) investor drops below 5% after in‑kind share payout - Stock Titan
5%+ passive stake in Nephros (NEPH) reported by Charles Davidson - Stock Titan
3.4M Nephros (NEPH) shares shift in Wexford transactions - Stock Titan
Nephros (NEPH) director adds shares via in-kind deal - Stock Titan
Nephros Inc. (NEPH) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com
Nephros Inc. (NEPH) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Nephros Inc. (NEPH) Peer Comparison – Compare with Others - Value Research
Nephros Inc. (NEPH) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Nephros Inc (NASDAQ: NEPH) Share Price, NEPH Stock News, NEPH Share Price & Updates - Kalkine
Nephros, Inc. Delivers Record Quarter Amid Margin Strain - The Globe and Mail
Wexford Capital adds Nephros (NEPH) shares in cashless option move - Stock Titan
Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat By Investing.com - Investing.com Nigeria
Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat By Investing.com - Investing.com India
Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat By Investing.com - Investing.com Canada
Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat By Investing.com - Investing.com UK
Benchmark reiterates Speculative Buy on Nephros stock after Q2 beat - Investing.com
Q3 EPS Estimates for Nephros Raised by Northland Securities - MarketBeat
August 2026's Promising Penny Stocks - Sahm
Nephros (NEPH) director Arthur Amron granted 2,418 shares, holds 140,874 - Stock Titan
August 2026's Promising Penny Stocks - simplywall.st
Nephros (NEPH) Q2 2026 Earnings Call Transcript - AOL.com
Nephros (NEPH) Q2 2026 Earnings Call Transcript - The Globe and Mail
Northland Securities Maintains Nephros(NEPH.US) With Hold Rating, Raises Target Price to $4.75 - Moomoo
Nephros Inc (NEPH) Stock Price, News, Earnings & Company Profile - RTTNews
NEPHROS INC Q2 2026: Revenue $6.02M, Net income $1.2M, EPS $0.11— 10-Q Summary - TradingView
Nephros (NEPH) boosts Q2 2026 profit on revenue growth and tariff refund - Stock Titan
NEPH Q2 2026 Earnings: EPS Soars 3448% Above ExpectationsEarnings Whisper Number - vinanet.vn
Nephros, Inc. (NPJP.F) stock price, news, quote and history - Yahoo Finance UK
Maxim Group Sticks to Their Buy Rating for Nephros (NEPH) - The Globe and Mail
Nephros Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Nephros, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
NEPH Looks 23.8% Overvalued on GF Value™ - GuruFocus
Is Nephros Inc (NEPH) Overvalued After Q2 Earnings Beat? EPS at - GuruFocus
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ... By GuruFocus - Investing.com Canada
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ... - Yahoo Finance
NEPH Q1 2026 Earnings: EPS Lands at $0.01, Barely Misses Estimate as Shares Rally 9.38%Cash Flow Report - vinanet.vn
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Re - GuruFocus
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ... - Yahoo Finance UK
NEPH: Record revenue and net income driven by broad-based growth and operational execution - TradingView
Earnings call transcript: Nephros posts Q2 2026 growth, shares rise premarket - Investing.com
Nephros Q2 2026 Earnings: Revenue Rises 36% as Tariff Refund Lifts Margins - TradingKey
Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026 - The Manila Times
Q2 2026 Nephros Inc Earnings Call Transcript - GuruFocus
Nephros Inc Stock (NEPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nephros Inc Stock (NEPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Krandel Judy | Chief Financial Officer |
Mar 23 '26 |
Option Exercise |
1.71 |
68,861 |
117,752 |
68,861 |
| Banks Robert R. Jr. | President and CEO |
Mar 23 '26 |
Option Exercise |
1.44 |
120,000 |
172,800 |
190,000 |
0.92%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):